Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

RIFAMPICIN CRS (100 MG)

RIFAMPICIN CRS (100 MG)

13292-46-1

DISCOVER
Ricinine

Ricinine

524-40-3

DISCOVER
RIFAMPICIN QUINONE CRS (50 MG)

RIFAMPICIN QUINONE CRS (50 MG)

13983-13-6

DISCOVER
Raloxifene

Raloxifene

84449-90-1

DISCOVER
Retrorsine N-Oxide

Retrorsine N-Oxide

15503-86-3

DISCOVER
Rosmarinic acid

Rosmarinic acid

20283-92-5

DISCOVER
RIFAMYCIN B CRS (25 MG)

RIFAMYCIN B CRS (25 MG)

13929-35-6

DISCOVER
Rutin

Rutin

153-18-4

DISCOVER
RIFAMYCIN S CRS (100 MG)

RIFAMYCIN S CRS (100 MG)

13553-79-2

DISCOVER
Ramiprilat

Ramiprilat

87269-97-4

DISCOVER
Rosiglitazone

Rosiglitazone

122320-73-4

DISCOVER
RIFAMYCIN SODIUM CRS (150 MG)

RIFAMYCIN SODIUM CRS (150 MG)

14897-39-3

DISCOVER